Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, Katalin, Buckstein, Michael, Ni, Houping, Weissman, Drew·2005·Immunity

Cited by (1,004)

Items 701–800 of 1,004

  1. Mechanisms of immune system activation in mammalians by small interfering RNA (siRNA)
    Behzad Mansoori, Ali Mohammadi, Solmaz Shirjang, Behzad Baradaran · 2015 · Artificial Cells Nanomedicine and Biotechnology
  2. Impaired expression of indoleamine 2, 3‐dioxygenase in monocyte‐derived dendritic cells in response to Toll‐like receptor‐7/8 ligands
    Gro Furset, Yngvar Fløisand, Mouldy Sioud · 2007 · Immunology
  3. Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics
    Marina A. Dobrovolskaia, Scott E. McNeil · 2015 · Expert Opinion on Biological Therapy
  4. Synthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review
    Oliwia Andries, Tasuku Kitada, Katie Bodner, Niek N. Sanders, Ron Weiss · 2015 · Expert Review of Vaccines
  5. Post-Transcriptional Regulation of Viral RNA through Epitranscriptional Modification
    David Courtney · 2021 · Cells
  6. The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
    Xinwei Xu, Jintu Huang, Dickson Kofi Wiredu Ocansey, Yuxuan Xia, Zihan Zhao, Zhiwei Xu, Yongmin Yan, Xu Zhang, Fei Mao · 2021 · Journal of Inflammation Research
  7. Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA
    Blakney, Anna K., McKay, Paul F., Christensen, Dennis, Yus, Bárbara Ibarzo, Aldon, Yoann, Follmann, Frank, Shattock, Robin J. · 2019 · Journal of Controlled Release
  8. Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs
    Zhong, Zifu, McCafferty, Séan, Opsomer, Lisa, Wang, Haixiu, Huysmans, Hanne, De Temmerman, Joyca, Lienenklaus, Stefan, Portela Catani, João Paulo, Combes, Francis, Sanders, Niek N. · 2021 · Molecular Therapy
  9. Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID‐19 vaccine
    Wongi Woo, Ah Young Kim, Dong Keon Yon, Seung Won Lee, Jimin Hwang, Louis Jacob, Ai Koyanagi, Min S. Kim, Duk H. Moon, Jo W. Jung et al. · 2021 · Journal of Medical Virology
  10. Regulation of antiviral innate immunity by chemical modification of viral RNA
    Na Li, Tariq M. Rana · 2022 · Wiley Interdisciplinary Reviews - RNA
  11. Aging-associated accumulation of mitochondrial DNA mutations in tumor origin
    Minghua Kong, Lishu Guo, Weilin Xu, Chengpeng He, Xiaoyan Jia, Zhiyao Zhao, Zhenglong Gu · 2022 · Life Medicine
  12. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination
    Aurélien Sokal, Paul Bastard, Pascal Chappert, Giovanna Barba Spaeth, Slim Fourati, Alexis Vandenberghe, Pauline Lagouge-Roussey, Isabelle Meyts, Adrian Gervais, Magali Bouvier‐Alias et al. · 2022 · The Journal of Experimental Medicine
  13. The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics
    Albert Radikovich Muslimov, Valeriy Tereshchenko, Daniil Shevyrev, Anna S. Rogova, Kirill Viktorovich Lepik, Vasiliy V. Reshetnikov, Roman A. Ivanov · 2023 · International Journal of Molecular Sciences
  14. Advances in the design and delivery of RNA vaccines for infectious diseases
    Abhijeet Girish Lokras, Thomas Rønnemoes Bobak, Saahil Sandeep Baghel, Federica Sebastiani, Camilla Foged · 2024 · Advanced Drug Delivery Reviews
  15. siRNA‐induced immunostimulation through TLR7 promotes antitumoral activity against HPV‐driven tumors in vivo
    Norliana Khairuddin, Michael Paul Gantier, Stephen J. Blake, Sherry Y. Wu, Mark A. Behlke, Bryan R.G. Williams, Nigel A.J. McMillan · 2011 · Immunology and Cell Biology
  16. Improving N6-methyladenosine site prediction with heuristic selection of nucleotide physical–chemical properties
    Ming Zhang, Jia-Wei Sun, Zi Liu, Mingwu Ren, Hong‐Bin Shen, Dong‐Jun Yu · 2016 · Analytical Biochemistry
  17. Gene/environment interactions in the pathogenesis of autoimmunity: New insights on the role of Toll-like receptors
    Elena Gianchecchi, Alessandra Fierabracci · 2015 · Autoimmunity Reviews
  18. A retrovirus packages nascent host noncoding RNAs from a novel surveillance pathway
    Eckwahl, Matthew J., Sim, Soyeong, Smith, Derek, Telesnitsky, Alice, Wolin, Sandra L. · 2015 · Genes & Development
  19. Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
    Paolo Bellavite, Alessandra Ferraresi, Ciro Isidoro · 2023 · Biomedicines
  20. Innate immune regulations and various siRNA modalities
    Anju Kaushal · 2023 · Drug Delivery and Translational Research
  21. Messenger RNA-Based Therapeutics and Vaccines: What’s beyond COVID-19?
    Dongqiao Li, Cynthia Liu, Yingzhu Li, Rumiana Tenchov, Janet M. Sasso, Di Zhang, Dan Li, Lixue Zou, Xuezhao Wang, Qiongqiong Angela Zhou · 2023 · ACS Pharmacology & Translational Science
  22. Computational design of mRNA vaccines
    Yoo-Ah Kim, Kambiz Mousavi, A Khalili Yazdi, Magdalena Zwierzyna, Marco Cardinali, Dillion M. Fox, Thomas Peel, Jeff Coller, Kunal Aggarwal, Giulietta Maruggi · 2023 · Vaccine
  23. mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions
    Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma, Petra Berényi, Réka Facskó, Henriette Farkas, László Dézsi, Carlo Heirman, Stefaan De Koker, Raymond Michel Schiffelers et al. · 2024 · International Journal of Molecular Sciences
  24. The tRNA Val half: A strong endogenous Toll-like receptor 7 ligand with a 5′-terminal universal sequence signature
    Kamlesh Pawar, Takuya Kawamura, Yohei Kirino · 2024 · Proceedings of the National Academy of Sciences
  25. Multi-level regulation of cellular recognition of viral dsRNA
    Alys Peisley, Sun Hur · 2012 · Cellular and Molecular Life Sciences
  26. Hepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1
    Françoise Gondois‐Rey, Clélia Dental, Philippe Halfon, Thomas F. Baumert, Daniel Olive, Ivan Hirsch · 2009 · PLoS ONE
  27. Improved RNA modification mapping of cellular non-coding RNAs using C- and U-specific RNases
    Priti Thakur, Mariana Estevez, Peter A. Lobue, Patrick A. Limbach, Balasubrahmanyam Addepalli · 2019 · The Analyst
  28. Transcription, mRNA Export, and Immune Evasion Shape the Codon Usage of Viruses
    Christine Mordstein, Laura Cano, Atahualpa Castillo-Morales, Bethan Young, Alexander T Ho, Alan M. Rice, Michael Andre Liss, Laurence D. Hurst, Grzegorz R. Kudla · 2021 · Genome Biology and Evolution
  29. Emerging immunomodulatory strategies for cell therapeutics
    Corrine Ying Xuan Chua, Allen Yujie Jiang, Tatiane Eufrásio-da-Silva, Alireza Dolatshahi‐Pirouz, Róbert Langer, Gorka Orive, Alessandro Grattoni · 2022 · Trends in biotechnology
  30. Polyplex designs for improving the stability and safety of RNA therapeutics
    Satoshi Uchida, Chun Yin Jerry Lau, Makoto Oba, Kanjiro Miyata · 2023 · Advanced Drug Delivery Reviews
  31. Epigenetic addition of m5C to HBV transcripts promotes viral replication and evasion of innate antiviral responses
    Shuang Ding, Haibin Liu, Lijuan Liu, Li Ma, Zhen Chen, Miao Zhu, Lishi Liu, Xueyan Zhang, Haojie Hao, Li Zuo et al. · 2024 · Cell Death and Disease
  32. Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation
    Jeonghwan Kim, Antony Jozić, Elissa Bloom, Brian Jones, Michael Marra, Namratha Turuvekere Vittala Murthy, Yulia Eygeris, Gaurav Sahay · 2024 · ACS Nano
  33. Exogenous RNA surveillance by proton-sensing TRIM25
    Myeonghwan Kim, Youngjoon Pyo, Seong‐In Hyun, Minseok Jeong, Yeon Choi, V. Narry Kim · 2025 · Science
  34. Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration
    Sarah M. Johler, Joanna Rejman, Shan Guan, Joseph Rosenecker · 2015 · PLoS ONE
  35. Literature review of baseline information on non‐coding RNA (ncRNA) to support the risk assessment of ncRNA‐based genetically modified plants for food and feed
    Alberto Dávalos, Rossana Henriques, María Jesús Latasa, Moisés Laparra, Marı́a A. Coca · 2019 · EFSA Supporting Publications
  36. Programmable RNA base editing via targeted modifications
    Jinghui Song, Yuan Zhuang, Chengqi Yi · 2024 · Nature Chemical Biology
  37. Characterisation and analysis of mRNA critical quality attributes using liquid chromatography based methods
    Alexandra L.J. Webb, Emma N. Welbourne, Caroline A. Evans, Mark J. Dickman · 2025 · Journal of Chromatography A
  38. Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases
    Seyedeh Ghazal Moosavi, Niloufar Rahiman, Mahmoud Reza Jaafari, Leila Arabi · 2025 · Journal of Controlled Release
  39. Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasis
    Camille Guillerey, Melvyn T. Chow, Kim M. Miles, Stuart D. Olver, Jaclyn Sceneay, Kazuyoshi Takeda, Andreas Möller, Mark John Smyth · 2015 · OncoImmunology
  40. Synthetic mRNAs for manipulating cellular phenotypes: an overview
    Elgar Susanne Quabius, Guido Krupp · 2014 · New Biotechnology
  41. Bacterial RNAs activate innate immunity in Arabidopsis
    Bo‐Young Lee, Yongsoon Park, Soohyun Lee, Geun Cheol Song, Choong‐Min Ryu · 2015 · New Phytologist
  42. Promises and Challenges in Developing RNAi as a Research Tool and Therapy
    Mouldy Sioud · 2010 · Methods in molecular biology
  43. Nucleic Acid Polymers Are Active against Hepatitis Delta Virus InfectionIn Vitro
    Frauke Beilstein, Matthieu Blanchet, Andrew Vaillant, Camille Sureau · 2017 · Journal of Virology
  44. A central role for PI3K-AKT signaling pathway in linking SAMHD1-deficiency to the type I interferon signature
    Changhoon Oh, Jeongmin Ryoo, Kiwon Park, Baek Kim, Michele B. Daly, Dong-Yeon Cho, Kwangseog Ahn · 2018 · Scientific Reports
  45. mRNA Vaccines against Flaviviruses
    Wollner, Clayton J., Richner, Justin M. · 2021 · Vaccines
  46. Profiles of current COVID-19 vaccines
    Franz Xaver Heinz, Karin Stiasny · 2021 · Wiener klinische Wochenschrift
  47. Shaping the Innate Immune Response Through Post-Transcriptional Regulation of Gene Expression Mediated by RNA-Binding Proteins
    Anissa Guillemin, Anuj Kumar, Mélanie Wencker, Emiliano P. Ricci · 2022 · Frontiers in Immunology
  48. Atelocollagen-mediated Systemic Delivery Prevents Immunostimulatory Adverse Effects of siRNA in Mammals
    Shinichiro Inaba, Shunji Nagahara, Naoki Makita, Yuzo Tarumi, Takuji Ishimoto, Seiichi Matsuo, Kenji Kadomatsu, Yoshifumi Takei · 2011 · Molecular Therapy
  49. Sequence-dependent off-target inhibition of TLR7/8 sensing by synthetic microRNA inhibitors
    Soroush T. Sarvestani, H. James Stunden, Mark A. Behlke, Samuel C. Forster, Claire E. McCoy, Michelle D. Tate, Jonathan Ferrand, Kim A. Lennox, Eicke Latz, Bryan R.G. Williams et al. · 2014 · Nucleic Acids Research
  50. Innate immunity networks during infection withBorrelia burgdorferi
    Marije Oosting, Kathrin Buffen, Jos W. M. van der Meer, Mihai Gheorghe Netea, Leo A. B. Joosten · 2014 · Critical Reviews in Microbiology
  51. 2-Thiouracil deprived of thiocarbonyl function preferentially base pairs with guanine rather than adenine in RNA and DNA duplexes
    Elżbieta Sochacka, Roman H. Szczepanowski, Marek Cypryk, Milena Sobczak, Magdalena Janicka, Karina Kraszewska, Paulina Bartos, Anna Chwialkowska, Barbara Nawrot · 2015 · Nucleic Acids Research
  52. LncRNAs in the Type I Interferon Antiviral Response
    Beatriz Suárez, Laura Prats-Mari, Juan Pablo Unfried, Puri Fortes · 2020 · International Journal of Molecular Sciences
  53. Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2
    Mohd Zulkifli Salleh, Mohd Nor Norazmi, Zakuan Zainy Deris · 2022 · PeerJ
  54. Reprogramming of Urine-Derived Renal Epithelial Cells into iPSCs Using srRNA and Consecutive Differentiation into Beating Cardiomyocytes
    Heidrun Steinle, Marbod Weber, Andreas Behring, Ulrike Angelika Mau-Holzmann, Christiane VON OHLE, Aron‐Frederik Popov, Christian Schlensak, Hans Peter Wendel, Meltem Avci‐Adali · 2019 · Molecular Therapy — Nucleic Acids
  55. Chemically Modified mocRNAs for Highly Efficient Protein Expression in Mammalian Cells
    Abhishek J. Aditham, Hailing Shi, Jianting Guo, Hu Zeng, Yiming Zhou, Sarah D. Wade, Jiahao Huang, Jia Liu B, Xiao Wang · 2022 · ACS Chemical Biology
  56. RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases
    Nada Bejar, Trinh To Tat, Dániel Kiss · 2022 · Current Atherosclerosis Reports
  57. Engineered mRNA Delivery Systems for Biomedical Applications
    Ji Wang, Haofang Zhu, Jingjing Gan, Gaofeng Liang, Ling Li, Yuanjin Zhao · 2023 · Advanced Materials
  58. Lipid Nanoparticle-Based Delivery SystemA Competing Place for mRNA Vaccines
    Xinyu Zhang, Yuanfang Li, Zehua Zhou · 2024 · ACS Omega
  59. Electrochemical Glycosylation via Halogen-Atom-Transfer for C -Glycoside Assembly
    Jun Wu, Purushothaman Rajeshwaran, Felix Kallert, Simon L. Homölle, Lutz Ackermann · 2024 · ACS Catalysis
  60. Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70
    Byron Brook, Valerie Duval, Soumik Barman, Lauren Speciner, Cali Sweitzer, Asad Khanmohammed, Manisha Menon, Kimberly Foster, Pallab Ghosh, Kimia Abedi et al. · 2024 · Science Translational Medicine
  61. Direct RNA sequencing enables improved transcriptome assessment and tracking of RNA modifications for medical applications
    Charlotte Hewel, Anna Wierczeiko, Johannes Miedema, Johannes H. Friedrich, Felix Hofmann, Stephan Weißbach, Vincent Dietrich, Laura Holthöfer, Verena Haug, Stefan Mündnich et al. · 2025 · Nucleic Acids Research
  62. Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses
    Diana Castaño, Emily Bettini, Binod Kumar, Aleksey Chudnovskiy, Anna Siv, Giulia Protti, Sandra Nakandakari-Higa, Simona Ceglia, Nina De Luna, Joy E. Chiu et al. · 2025 · Cell
  63. Staying on message: design principles for controlling nonspecific responses to siRNA
    Shirley Samuel‐Abraham, Joshua N. Leonard · 2010 · FEBS Journal
  64. Probing RNA Modification Status at Single-Nucleotide Resolution in Total RNA
    Nian Liu, Tao Pan · 2015 · Methods in enzymology on CD-ROM/Methods in enzymology
  65. Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice
    Sebastian Rosigkeit, Martin Meng, Christian R. Grunwitz, Patrícia Gomes, Andreas Kreft, Nina Hayduk, Rosario Heck, Geethanjali Pickert, Kira Ziegler, Yasmin Abassi et al. · 2018 · Molecular Pharmaceutics
  66. MicroRNAs and their delivery in diabetic fibrosis
    Alexa Wonnacott, Laura Denby, Richard J. Coward, Donald J. Fraser, Timothy Bowen · 2021 · Advanced Drug Delivery Reviews
  67. Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment
    Md. Emranul Karim, Sheikh Tanzina Haque, Hamed Al-Busaidi, Athirah Bakhtiar, Kyi Kyi Tha, Mark M. Banaszak Holl, Ezharul Hoque Chowdhury · 2022 · Archives of Pharmacal Research
  68. Feeder‐Free Reprogramming of Human Fibroblasts with Messenger RNA
    Luigi A. Warren, Jiwu Wang · 2013 · Current Protocols in Stem Cell Biology
  69. Stronger together for in-cell translation: natural and unnatural base modified mRNA
    Lisa Bornewasser, Christof Domnick, Stephanie Kath‐Schorr · 2022 · Chemical Science
  70. Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art
    Luke H. Rhym, Daniel G. Anderson · 2022 · Med
  71. N1-methyl-pseudouridine is incorporated with higher fidelity than pseudouridine in synthetic RNAs
    Tien-Hao Chen, Vladimir Potapov, Nan Dai, Jennifer L. Ong, Bijoyita Roy · 2022 · Scientific Reports
  72. Bioinspired Lipid Nanocarriers for RNA Delivery
    Alex Golubovic, Shannon Tsai, Bowen Li · 2023 · ACS Bio & Med Chem Au
  73. Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
    Cynthia M. Rohde, Claudia Lindemann, Michael A. Giovanelli, Rani S. Sellers, Jan Diekmann, Shambhunath Choudhary, Lila Ramaiah, Annette B. Vogel, Yana Chervona, Alexander Muik et al. · 2023 · Vaccines
  74. The emerging potential of siRNA nanotherapeutics in treatment of arthritis
    Anjali Kumari, Amanpreet Kaur, Geeta Aggarwal · 2023 · Asian Journal of Pharmaceutical Sciences
  75. Therapeutic synthetic and natural materials for immunoengineering
    Anna Slezak, Kevin Chang, Samir Hossainy, Aslan Mansurov, Stuart J. Rowan, Jeffrey A. Hubbell, Mustafa Ozgur Guler · 2024 · Chemical Society Reviews
  76. Advances in Poultry Vaccines: Leveraging Biotechnology for Improving Vaccine Development, Stability, and Delivery
    Khaled Abdelaziz, Yosra A. Helmy, Alexander Yitbarek, Douglas C. Hodgins, Tamer A. Sharafeldin, Mohamed H. Selim · 2024 · Vaccines
  77. Current Analytical Strategies for mRNA-Based Therapeutics
    Julien Camperi, Kamalakar Chatla, Emily C. Freund, Carolina Galan, Steffen Lippold, Axel Guilbaud · 2025 · Molecules
  78. Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy
    Ingo Roehl, Stephan Seiffert, Celia Brikh, Jonathan Quinet, Catherine Jamard, Nadine Dorfler, Jennifer A. Lockridge, Lucyna Cova, Andrew Vaillant · 2017 · Molecular Therapy — Nucleic Acids
  79. Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics
    Aman Ishaqat, Andreas Herrmann · 2021 · Journal of the American Chemical Society
  80. Viral RNA N6-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus
    Miaoge Xue, Yuexiu Zhang, Haitao Wang, Elizabeth L. Kairis, Mijia Lu, Sadeem Ahmad, Zayed Attia, Olivia E. Harder, Zijie Scott Zhang, Jiangbo Wei et al. · 2021 · PLoS Pathogens
  81. Current strategies employed in the manipulation of gene expression for clinical purposes
    Hsing‐Chuan Tsai, Violena Pietrobon, Maoyu Peng, Suning Wang, Lihong Zhao, Francesco Maria Marincola, Qi Cai · 2022 · Journal of Translational Medicine
  82. Modulating the expression of tumor suppressor genes using activating oligonucleotide technologies as a therapeutic approach in cancer
    Georgina L. Gregory, Ian M. Copple · 2022 · Molecular Therapy — Nucleic Acids
  83. Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
    Yuxiang Zhao, Linchuan Gan, Dangjin Ke, Qi Chen, Yajuan Fu · 2023 · Journal of Translational Medicine
  84. A Novel Self‐Amplifying mRNA with Decreased Cytotoxicity and Enhanced Protein Expression by Macrodomain Mutations
    Yue Gong, Danni Yong, Gensheng Liu, Jiang Xu, Jun Ding, William W.-G. Jia · 2024 · Advanced Science
  85. Heart Regeneration: Opportunities and Challenges for Drug Discovery with Novel Chemical and Therapeutic Methods or Agents
    Alleyn T. Plowright, Ola Engkvist, Adrian L. Gill, Laurent Knerr, Qing‐Dong Wang · 2014 · Angewandte Chemie International Edition
  86. Therapeutic Delivery of mRNA: The Medium Is the Message
    R. Scott McIvor · 2011 · Molecular Therapy
  87. Novel ribonuclease activity of cusativin from Cucumis sativus for mapping nucleoside modifications in RNA
    Balasubrahmanyam Addepalli, Sarah Venus, Priti Thakur, Patrick A. Limbach · 2017 · Analytical and Bioanalytical Chemistry
  88. RNA regulatory processes in RNA virus biology
    Shaun T. Cross, Daniel Michalski, Megan R. Miller, Jeffrey Wilusz · 2019 · Wiley Interdisciplinary Reviews - RNA
  89. Optimizing Modified mRNA In Vitro Synthesis Protocol for Heart Gene Therapy
    Yoav Hadas, Nishat Sultana, Elias Youssef, Mohammad Tofael Kabir Sharkar, Keerat Kaur, Elena Chepurko, Lior Zangi · 2019 · Molecular Therapy — Methods & Clinical Development
  90. RNA N6-methyladenosine: a promising molecular target in metabolic diseases
    Yan Li, Jiawen Wang, Chunyan Huang, Meng Shen, Huakui Zhan, Keyang Xu · 2020 · Cell & Bioscience
  91. Pseudouridines in RNAs: switching atoms means shifting paradigms
    Ting‐Yu Lin, Rahul Mehta, Sebastian Glatt · 2021 · FEBS Letters
  92. Delivery of synthetic mRNAs for tissue regeneration
    Heidrun Steinle, Marbod Weber, Sandra Stoppelkamp, Katharina Große‐Berkenbusch, Sonia Golombek, Marbod Weber, Tuba Çanak-Ipek, Sarah-Maria Trenz, Christian Schlensak, Meltem Avci‐Adali · 2021 · Advanced Drug Delivery Reviews
  93. TLR Ignores Methylated RNA?
    Ken J. Ishii, Shizuo Akira · 2005 · Immunity
  94. An mRNA vaccine elicits STING-dependent antitumor immune responses
    Zhe Chen, Chaoyang Meng, Junhua Mai, Yongbin Liu, Hangwen Li, Haifa Shen · 2022 · Acta Pharmaceutica Sinica B
  95. Vaccination-Associated Myocarditis and Myocardial Injury
    Natasha Lipson Altman, Amber A. Berning, Sarah Mann, Robert A. Quaife, Edward Allen Gill, Scott R. Auerbach, Thomas Campbell, Michael R. Bristow · 2023 · Circulation Research
  96. Recognition of pathogen-associated nucleic acids by endosomal nucleic acid-sensing toll-like receptors
    Xiaobing He, Huaijie Jia, Zhizhong Jing, Ding Xiang Liu · 2013 · Acta Biochimica et Biophysica Sinica
  97. Host RNA Packaging by Retroviruses: A Newly Synthesized Story
    Matthew J. Eckwahl, Alice Telesnitsky, Sandra L. Wolin · 2016 · mBio
  98. Neue Modalitäten für schwierige Zielstrukturen in der Wirkstoffentwicklung
    Eric Valeur, Stéphanie M. Guéret, Hélène Adihou, Ranganath Gopalakrishnan, Malin Lemurell, Herbert Waldmann, Tom N. Grossmann, Alleyn T. Plowright · 2017 · Angewandte Chemie
  99. Nucleotide Modifications Decrease Innate Immune Response Induced by Synthetic Analogs of snRNAs and snoRNAs
    Grigory A. Stepanov, Evgenii S. Zhuravlev, Victoria О. Shender, Anna A. Nushtaeva, Evgenia Balakhonova, Elena Mozhaeva, Marat F. Kasakin, Vladimir V. Koval, Alexander A. Lomzov, Marat S. Pavlyukov et al. · 2018 · Genes
  100. 2′-O-methylation within prokaryotic and eukaryotic tRNA inhibits innate immune activation by endosomal Toll-like receptors but does not affect recognition of whole organisms
    Isabel Freund, Daniel K. Buhl, Sébastien Boutin, Annika Kötter, Florian Pichot, Virginie Marchand, Tim Vierbuchen, Holger Heine, Yuri Motorin, Mark Helm et al. · 2019 · RNA